ZA931064B - Derivatives of saturated nitrogen heterocycles. - Google Patents
Derivatives of saturated nitrogen heterocycles.Info
- Publication number
- ZA931064B ZA931064B ZA931064A ZA931064A ZA931064B ZA 931064 B ZA931064 B ZA 931064B ZA 931064 A ZA931064 A ZA 931064A ZA 931064 A ZA931064 A ZA 931064A ZA 931064 B ZA931064 B ZA 931064B
- Authority
- ZA
- South Africa
- Prior art keywords
- derivatives
- saturated nitrogen
- nitrogen heterocycles
- heterocycles
- saturated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH46092 | 1992-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA931064B true ZA931064B (en) | 1993-08-17 |
Family
ID=4187521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA931064A ZA931064B (en) | 1992-02-17 | 1993-02-16 | Derivatives of saturated nitrogen heterocycles. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5322852A (enExample) |
| EP (1) | EP0558443A1 (enExample) |
| JP (1) | JPH069558A (enExample) |
| KR (1) | KR930017874A (enExample) |
| AU (1) | AU3298193A (enExample) |
| CA (1) | CA2089533A1 (enExample) |
| IL (1) | IL104757A0 (enExample) |
| TW (1) | TW214545B (enExample) |
| ZA (1) | ZA931064B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2212118C (en) * | 1995-03-15 | 2007-07-31 | Novartis Ag | Piperidinyl-2-alkyl subst. linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation |
| TWI220143B (en) * | 1998-05-13 | 2004-08-11 | Solvay Pharm Gmbh | Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products |
| WO2009073620A2 (en) | 2007-11-30 | 2009-06-11 | Newlink Genetics | Ido inhibitors |
| EA022785B8 (ru) * | 2008-12-15 | 2016-06-30 | Тайджен Байотекнолоджи Ко., Лтд. | Стереоселективный синтез производных пиперидина |
| KR101796318B1 (ko) | 2009-07-31 | 2017-11-09 | 제이에스알 가부시끼가이샤 | 감방사선성 수지 조성물 및 그것에 이용되는 화합물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
| EP0369944A1 (de) * | 1988-11-18 | 1990-05-23 | Ciba-Geigy Ag | Substituierte Oxadiaminobutane |
| FR2644456B1 (fr) * | 1989-03-17 | 1991-07-05 | Rhone Poulenc Sante | Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent |
| EP0452264A1 (de) * | 1990-04-11 | 1991-10-16 | Ciba-Geigy Ag | Hydroxylamin-Verbindungen |
| EP0495750A3 (en) * | 1991-01-14 | 1992-09-16 | Ciba-Geigy Ag | Heterocyclic hydroxylamine |
-
1993
- 1993-01-30 TW TW082100576A patent/TW214545B/zh active
- 1993-02-09 EP EP93810079A patent/EP0558443A1/de not_active Withdrawn
- 1993-02-10 AU AU32981/93A patent/AU3298193A/en not_active Abandoned
- 1993-02-11 US US08/016,407 patent/US5322852A/en not_active Expired - Lifetime
- 1993-02-15 CA CA002089533A patent/CA2089533A1/en not_active Abandoned
- 1993-02-16 IL IL104757A patent/IL104757A0/xx unknown
- 1993-02-16 JP JP5026685A patent/JPH069558A/ja active Pending
- 1993-02-16 ZA ZA931064A patent/ZA931064B/xx unknown
- 1993-02-17 KR KR1019930002171A patent/KR930017874A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| TW214545B (enExample) | 1993-10-11 |
| KR930017874A (ko) | 1993-09-20 |
| IL104757A0 (en) | 1993-06-10 |
| US5322852A (en) | 1994-06-21 |
| AU3298193A (en) | 1993-08-19 |
| JPH069558A (ja) | 1994-01-18 |
| CA2089533A1 (en) | 1993-08-18 |
| EP0558443A1 (de) | 1993-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL307812A1 (en) | Substituted thiazolydinone derivatives | |
| IL100746A0 (en) | Nitrogen heterocycles | |
| HU9300744D0 (en) | 2-oxo-quinoline derivatives | |
| ZA922557B (en) | Nitrogen derivatives | |
| ZA93324B (en) | Heterocyclic derivatives | |
| IL104757A0 (en) | Derivatives of saturated nitrogen heterocycles | |
| ZA937988B (en) | Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives | |
| GB2270913B (en) | Chlordifluoromethoxyphenyl derivatives | |
| GB9005843D0 (en) | Nitrogen heterocycles | |
| GB9202633D0 (en) | Heterocyclic derivatives | |
| ZA931516B (en) | Substituted phenylquinazoline derivatives | |
| GB9216783D0 (en) | Heterocyclic derivatives | |
| GB9301388D0 (en) | Lathe | |
| ZA935128B (en) | Monensin derivatives | |
| GB9201429D0 (en) | Nitrogen derivatives | |
| GB9216772D0 (en) | Nitrogen derivatives | |
| GB9213474D0 (en) | Nitrogen derivatives | |
| GB9211290D0 (en) | Nitrogen derivatives | |
| ZA92434B (en) | Nitrogen heterocycles | |
| GB9011348D0 (en) | Nitrogen heterocycles | |
| GB9206421D0 (en) | Heterocyclic derivatives | |
| GB9216777D0 (en) | Heterocyclic derivatives | |
| GB9200633D0 (en) | Heterocyclic derivatives | |
| GB9226574D0 (en) | Heterocyclic derivatives | |
| GB9208387D0 (en) | Heterocyclic derivatives |